Digital Health Market Size, Share & Trends Analysis Report By Technology (Healthcare Analytics, mHealth), By Component (Hardware, Software, Services), By Application, By End-use, By Region,- Industry Analysis, Share, Growth, Regional Outlook and Forecasts, 2024-2033

Chapter 1. Digital Health Market: Methodology and Scope

1.1. Market Segmentation & Scope

1.2. Segment Definitions

1.2.1. Technology

1.2.2. Component

1.2.3. Application

1.2.4. End-use

1.3. Estimates and Forecast Timeline

1.4. Research Methodology

1.5. Information Procurement

1.5.1. Purchased Database

1.5.2. Internal Database

1.5.3. Secondary Sources

1.5.4. Primary Research

1.6. Information Analysis

1.6.1. Data Analysis Models

1.7. Market Formulation & Data Visualization

1.8. Model Details

1.8.1. Commodity Flow Analysis

1.9. List of Secondary Sources

1.10. Objectives

Chapter 2. Digital Health Market: Executive Summary

2.1. Market Snapshot

2.2. Segment Snapshot

2.2.1. Technology outlook

2.2.2. Component outlook

2.2.3. Application outlook

2.2.4. End-use outlook

2.2.5. Regional outlook

2.3. Competitive Landscape Snapshot

Chapter 3. Digital Health Market: Variables, Trends, & Scope

3.1. Market Lineage Outlook

3.2. Market Dynamics

3.2.1. Market Driver Analysis

3.2.1.1. Increasing adoption of digital healthcare

3.2.1.2. Shortage of medical professionals and increasing demand for healthcare

3.2.1.3. Rise in artificial intelligence, IoT, and big data

3.2.1.4. Growing adoption of mobile health applications

3.2.2. Market Restraint Analysis

3.2.2.1. Cybersecurity and privacy concerns

3.2.2.2. Lack of healthcare infrastructure

3.3. Case Study Analysis

3.3.1. End-use case studies

3.3.1.1. Case Study 1: Nova Hospital & Enovacom

3.3.1.2. Case Study 2: Apple & NHS Teams

3.4. Business Environment Analysis

3.4.1. Industry Analysis - Porter’s

3.4.1.1. Supplier power

3.4.1.2. Buyer power

3.4.1.3. Substitution threat

3.4.1.4. Threat of new entrant

3.4.1.5. Competitive rivalry

3.4.2. PESTEL Analysis

Chapter 4. Digital Health Market Segment Analysis, By Technology, 2021 - 2033 (USD Million)

4.1. Definition and Scope

4.2. Technology Segment Dashboard

4.3. Global Digital Health Market, by Technology, 2018 to 2030

4.4. Tele-Healthcare

4.4.1. Market estimates and forecasts, 2021 to 2033

4.4.2. Telecare

4.4.2.1. Market estimates and forecasts, 2021 to 2033

4.4.2.2. Activity monitoring

4.4.2.3. Market estimates and forecasts, 2021 to 2033

4.4.2.4. Remote medication management

4.4.2.5. Market estimates and forecasts, 2021 to 2033

4.4.3. Telehealth

4.4.3.1. Market estimates and forecasts, 2021 to 2033

4.4.3.2. Long-term care (LTC) monitoring

4.4.3.3. Market estimates and forecasts, 2021 to 2033

4.4.3.4. Video consultation

4.4.3.5. Market estimates and forecasts, 2021 to 2033

4.5. mHealth

4.5.1. Market estimates and forecasts, 2021 to 2033

4.5.2. Wearables & Connected Medical Devices

4.5.2.1. Market estimates and forecasts, 2021 to 2033

4.5.2.2. Vital Sign Monitoring Devices

4.5.2.2.1.Market estimates and forecasts, 2021 to 2033

4.5.2.2.2.Heart Rate Monitors

4.5.2.2.2.1. Market estimates and forecasts, 2021 to 2033

4.5.2.2.3.Activity Monitors

4.5.2.2.3.1. Market estimates and forecasts, 2021 to 2033

4.5.2.2.4.Electrocardiographs

4.5.2.2.4.1. Market estimates and forecasts, 2021 to 2033

4.5.2.2.5.Pulse Oximeters

4.5.2.2.5.1. Market estimates and forecasts, 2021 to 2033

4.5.2.2.6.Spirometers

4.5.2.2.6.1. Market estimates and forecasts, 2021 to 2033

4.5.2.2.7.Blood Pressure Monitors

4.5.2.2.7.1. Market estimates and forecasts, 2021 to 2033

4.5.2.2.8.Others

4.5.2.2.8.1. Market estimates and forecasts, 2021 to 2033

4.5.2.3. Sleep Monitoring Devices

4.5.2.3.1.Market estimates and forecasts, 2021 to 2033

4.5.2.3.2.Sleep trackers.

4.5.2.3.2.1. Market estimates and forecasts, 2021 to 2033

4.5.2.3.3.Wrist Actigraphs

4.5.2.3.3.1. Market estimates and forecasts, 2021 to 2033

4.5.2.3.4.Polysomnographs

4.5.2.3.4.1. Market estimates and forecasts, 2021 to 2033

4.5.2.3.5.Others

4.5.2.3.5.1. Market estimates and forecasts, 2021 to 2033

4.5.2.4. Electrocardiographs Fetal and Obstetric Devices

4.5.2.4.1.Market estimates and forecasts, 2021 to 2033

4.5.2.5. Neuromonitoring Devices

4.5.2.5.1.Market estimates and forecasts, 2021 to 2033

4.5.2.5.2.Electroencephalographs

4.5.2.5.3.Market estimates and forecasts, 2021 to 2033

4.5.2.5.4.Electromyographs

4.5.2.5.5.Market estimates and forecasts, 2021 to 2033

4.5.2.5.6.Others

4.5.2.5.7.Market estimates and forecasts, 2021 to 2033

4.5.3. mHealth Apps

4.5.3.1. Market estimates and forecasts, 2021 to 2033

4.5.3.2. Medical Apps

4.5.3.2.1.Market estimates and forecasts, 2021 to 2033

4.5.3.2.2.Women's Health

4.5.3.2.2.1. Market estimates and forecasts, 2021 to 2033

4.5.3.2.2.2. Fitness and Nutrition

4.5.3.2.2.2.1. Market estimates and forecasts, 2021 to 2033

4.5.3.2.2.3. Menstrual Health

4.5.3.2.2.3.1. Market estimates and forecasts, 2021 to 2033

4.5.3.2.2.4. Pregnancy Tracking & Postpartum Care

4.5.3.2.2.4.1. Market estimates and forecasts, 2021 to 2033

4.5.3.2.2.5. Menopause

4.5.3.2.2.5.1. Market estimates and forecasts, 2021 to 2033

4.5.3.2.2.6. Disease Management

4.5.3.2.2.6.1. Market estimates and forecasts, 2021 to 2033

4.5.3.2.2.7. Others

4.5.3.2.2.7.1. Market estimates and forecasts, 2021 to 2033

4.5.3.2.3.Chronic Disease Management Apps

4.5.3.2.3.1. Market estimates and forecasts, 2021 to 2033

4.5.3.2.3.2. Diabetes Management Apps

4.5.3.2.3.2.1. Market estimates and forecasts, 2021 to 2033

4.5.3.2.3.3. Blood Pressure and ECG Monitoring Apps

4.5.3.2.3.3.1. Market estimates and forecasts, 2021 to 2033

4.5.3.2.3.4. Mental Health Management Apps

4.5.3.2.3.4.1. Market estimates and forecasts, 2021 to 2033

4.5.3.2.3.5. Cancer Management Apps

4.5.3.2.3.5.1. Market estimates and forecasts, 2021 to 2033

4.5.3.2.3.6. Obesity Management Apps

4.5.3.2.3.6.1. Market estimates and forecasts, 2021 to 2033

4.5.3.2.3.7. Other Chronic Disease Management Apps

4.5.3.2.3.7.1. Market estimates and forecasts, 2021 to 2033

4.5.3.2.4.Personal Health Record Apps

4.5.3.2.4.1. Market estimates and forecasts, 2021 to 2033

4.5.3.2.5.Medication Management Apps

4.5.3.2.5.1. Market estimates and forecasts, 2021 to 2033

4.5.3.2.6.Diagnostic Apps

4.5.3.2.6.1. Market estimates and forecasts, 2021 to 2033

4.5.3.2.7.Remote Monitoring Apps

4.5.3.2.7.1. Market estimates and forecasts, 2021 to 2033

4.5.3.2.8.Others (Medical Reference, Professional Networking, Healthcare Education)

4.5.3.2.8.1. Market estimates and forecasts, 2021 to 2033

4.5.3.3. Fitness Apps

4.5.3.3.1.Market estimates and forecasts, 2021 to 2033

4.5.4. Services

4.5.4.1. Market estimates and forecasts, 2021 to 2033

4.5.4.2. Monitoring Services

4.5.4.2.1.Market estimates and forecasts, 2021 to 2033

4.5.4.2.2.Independent Aging Solutions

4.5.4.2.2.1. Market estimates and forecasts, 2021 to 2033

4.5.4.2.3.Chronic Disease Management & Post-Acute Care Services

4.5.4.2.3.1. Market estimates and forecasts, 2021 to 2033

4.5.4.3. Diagnosis Services

4.5.4.3.1.Market estimates and forecasts, 2021 to 2033

4.5.4.4. Healthcare Systems Strengthening Services

4.5.4.4.1.Market estimates and forecasts, 2021 to 2033

4.5.4.5. Others

4.5.4.5.1.Market estimates and forecasts, 2021 to 2033

4.6. Digital Health Systems

4.6.1. Market estimates and forecasts, 2021 to 2033

4.6.2. EHR

4.6.2.1. Market estimates and forecasts, 2021 to 2033

4.6.3. E-prescribing Systems

4.6.3.1. Market estimates and forecasts, 2021 to 2033

4.7. Healthcare Analytics

4.7.1. Market estimates and forecasts, 2021 to 2033

Chapter 5. Digital Health Market: Segment Analysis, by Component, 2021 - 2033 (USD Million)

5.1. Definition and Scope

5.2. Component Segment Dashboard

5.3. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following

5.4. Software

5.4.1. Market estimates and forecasts, 2021 to 2033

5.5. Hardware

5.5.1. Market estimates and forecasts, 2021 to 2033

5.6. Services

5.6.1. Market estimates and forecasts, 2021 to 2033

Chapter 6. Digital Health Market: Segment Analysis, by Application, 2021 - 2033 (USD Million)

6.1. Definition and Scope

6.2. Application Segment Dashboard

6.3. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following

6.4. Obesity

6.4.1. Market estimates and forecasts, 2021 to 2033

6.5. Diabetes

6.5.1. Market estimates and forecasts, 2021 to 2033

6.6. Cardiovascular

6.6.1. Market estimates and forecasts, 2021 to 2033

6.7. Respiratory Diseases

6.7.1. Market estimates and forecasts, 2021 to 2033

6.8. Others

6.8.1. Market estimates and forecasts, 2021 to 2033

Chapter 7. Digital Health Market: Segment Analysis, by End-use, 2021 - 2033 (USD Million)

7.1. Definition and Scope

7.2. End-use Segment Dashboard

7.3. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following

7.4. Patients

7.4.1. Market estimates and forecasts, 2021 to 2033

7.5. Providers

7.5.1. Market estimates and forecasts, 2021 to 2033

7.6. Payers

7.6.1. Market estimates and forecasts, 2021 to 2033

7.7. Others

7.7.1. Market estimates and forecasts, 2021 to 2033

Chapter 8. Digital Health Market: Segment Analysis, by Region, by Technology, by Component, by Application, by End Use, 2021 - 2033 (USD Million)

8.1. Definition & Scope

8.2. Regional Market Share Analysis, 2023 & 2030

8.3. Regional Market Dashboard

8.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030:

8.5. SWOT Analysis

8.6. North America

8.6.1. U.S.

8.6.1.1. Key country dynamics

8.6.1.2. Regulatory framework/ reimbursement structure

8.6.1.3. Competitive scenario

8.6.1.4. U.S. market estimates and forecasts, 2021 to 2033

8.6.2. Canada

8.6.2.1. Key country dynamics

8.6.2.2. Regulatory framework/ reimbursement structure

8.6.2.3. Competitive scenario

8.6.2.4. Canada market estimates and forecasts, 2021 to 2033

8.7. Europe

8.7.1. UK

8.7.1.1. Key country dynamics

8.7.1.2. Regulatory framework/ reimbursement structure

8.7.1.3. Competitive scenario

8.7.1.4. UK market estimates and forecasts, 2021 to 2033

8.7.2. Germany

8.7.2.1. Key country dynamics

8.7.2.2. Regulatory framework/ reimbursement structure

8.7.2.3. Competitive scenario

8.7.2.4. Germany market estimates and forecasts, 2021 to 2033

8.7.3. France

8.7.3.1. Key country dynamics

8.7.3.2. Regulatory framework/ reimbursement structure

8.7.3.3. Competitive scenario

8.7.3.4. France market estimates and forecasts, 2021 to 2033

8.7.4. Italy

8.7.4.1. Key country dynamics

8.7.4.2. Regulatory framework/ reimbursement structure

8.7.4.3. Competitive scenario

8.7.4.4. Italy market estimates and forecasts, 2021 to 2033

8.7.5. Spain

8.7.5.1. Key country dynamics

8.7.5.2. Regulatory framework/ reimbursement structure

8.7.5.3. Competitive scenario

8.7.5.4. Spain market estimates and forecasts, 2021 to 2033

8.7.6. Norway

8.7.6.1. Key country dynamics

8.7.6.2. Regulatory framework/ reimbursement structure

8.7.6.3. Competitive scenario

8.7.6.4. Norway market estimates and forecasts, 2021 to 2033

8.7.7. Sweden

8.7.7.1. Key country dynamics

8.7.7.2. Regulatory framework/ reimbursement structure

8.7.7.3. Competitive scenario

8.7.7.4. Sweden market estimates and forecasts, 2021 to 2033

8.7.8. Denmark

8.7.8.1. Key country dynamics

8.7.8.2. Regulatory framework/ reimbursement structure

8.7.8.3. Competitive scenario

8.7.8.4. Denmark market estimates and forecasts, 2021 to 2033

8.8. Asia Pacific

8.8.1. Japan

8.8.1.1. Key country dynamics

8.8.1.2. Regulatory framework/ reimbursement structure

8.8.1.3. Competitive scenario

8.8.1.4. Japan market estimates and forecasts, 2021 to 2033

8.8.2. China

8.8.2.1. Key country dynamics

8.8.2.2. Regulatory framework/ reimbursement structure

8.8.2.3. Competitive scenario

8.8.2.4. China market estimates and forecasts, 2021 to 2033

8.8.3. India

8.8.3.1. Key country dynamics

8.8.3.2. Regulatory framework/ reimbursement structure

8.8.3.3. Competitive scenario

8.8.3.4. India market estimates and forecasts, 2021 to 2033

8.8.4. Australia

8.8.4.1. Key country dynamics

8.8.4.2. Regulatory framework/ reimbursement structure

8.8.4.3. Competitive scenario

8.8.4.4. Australia market estimates and forecasts, 2021 to 2033

8.8.5. South Korea

8.8.5.1. Key country dynamics

8.8.5.2. Regulatory framework/ reimbursement structure

8.8.5.3. Competitive scenario

8.8.5.4. South Korea market estimates and forecasts, 2021 to 2033

8.8.6. Singapore

8.8.6.1. Key country dynamics

8.8.6.2. Regulatory framework/ reimbursement structure

8.8.6.3. Competitive scenario

8.8.6.4. Singapore market estimates and forecasts, 2021 to 2033

8.9. Latin America

8.9.1. Brazil

8.9.1.1. Key country dynamics

8.9.1.2. Regulatory framework/ reimbursement structure

8.9.1.3. Competitive scenario

8.9.1.4. Brazil market estimates and forecasts, 2021 to 2033

8.9.2. Mexico

8.9.2.1. Key country dynamics

8.9.2.2. Regulatory framework/ reimbursement structure

8.9.2.3. Competitive scenario

8.9.2.4. Mexico market estimates and forecasts, 2021 to 2033

8.9.3. Argentina

8.9.3.1. Key country dynamics

8.9.3.2. Regulatory framework/ reimbursement structure

8.9.3.3. Competitive scenario

8.9.3.4. Argentina market estimates and forecasts, 2021 to 2033

8.10. MEA

8.10.1. South Africa

8.10.1.1. Key country dynamics

8.10.1.2. Regulatory framework/ reimbursement structure

8.10.1.3. Competitive scenario

8.10.1.4. South Africa market estimates and forecasts, 2021 to 2033

8.10.2. Saudi Arabia

8.10.2.1. Key country dynamics

8.10.2.2. Regulatory framework/ reimbursement structure

8.10.2.3. Competitive scenario

8.10.2.4. Saudi Arabia market estimates and forecasts 2021 to 2033

8.10.3. UAE

8.10.3.1. Key country dynamics

8.10.3.2. Regulatory framework/ reimbursement structure

8.10.3.3. Competitive scenario

8.10.3.4. UAE market estimates and forecasts, 2021 to 2033

8.10.4. Kuwait

8.10.4.1. Key country dynamics

8.10.4.2. Regulatory framework/ reimbursement structure

8.10.4.3. Competitive scenario

8.10.4.4. Kuwait market estimates and forecasts, 2021 to 2033

Chapter 9. Competitive Landscape

9.1. Recent Developments & Impact Analysis, By Key Market Participants

9.2. Company/Competition Categorization

9.2.1. Innovators

9.3. Vendor Landscape

9.3.1. List of key distributors and channel partners

9.3.2. Key customers

9.3.3. Key company market share analysis, 2023

9.3.4. Cerner Corporation (Oracle)

9.3.4.1. Company overview

9.3.4.2. Financial performance

9.3.4.3. Product benchmarking

9.3.4.4. Strategic initiatives

9.3.5. Allscripts (Veradigm LLC)

9.3.5.1. Company overview

9.3.5.2. Financial performance

9.3.5.3. Product benchmarking

9.3.5.4. Strategic initiatives

9.3.6. Apple, Inc.

9.3.6.1. Company overview

9.3.6.2. Financial performance

9.3.6.3. Product benchmarking

9.3.6.4. Strategic initiatives

9.3.7. Telefónica S.A.

9.3.7.1. Company overview

9.3.7.2. Financial performance

9.3.7.3. Product benchmarking

9.3.7.4. Strategic initiatives

9.3.8. Mckesson Corporation

9.3.8.1. Company overview

9.3.8.2. Financial performance

9.3.8.3. Product benchmarking

9.3.8.4. Strategic initiatives

9.3.9. QSI Management, LLC

9.3.9.1. Company overview

9.3.9.2. Financial performance

9.3.9.3. Product benchmarking

9.3.9.4. Strategic initiatives

9.3.10. AT&T

9.3.10.1. Company overview

9.3.10.2. Financial performance

9.3.10.3. Product benchmarking

9.3.10.4. Strategic initiatives

9.3.11. Vodafone Group

9.3.11.1. Company overview

9.3.11.2. Financial performance

9.3.11.3. Product benchmarking

9.3.11.4. Strategic initiatives

9.3.12. AirStrip Technologies

9.3.12.1. Company overview

9.3.12.2. Financial performance

9.3.12.3. Product benchmarking

9.3.12.4. Strategic initiatives

9.3.13. Google, Inc.

9.3.13.1. Company overview

9.3.13.2. Financial performance

9.3.13.3. Product benchmarking

9.3.13.4. Strategic initiatives

9.3.14. Samsung Electronics Co., Ltd., Inc.

9.3.14.1. Company overview

9.3.14.2. Financial performance

9.3.14.3. Product benchmarking

9.3.14.4. Strategic initiatives

9.3.15. HiMS

9.3.15.1. Company overview

9.3.15.2. Financial performance

9.3.15.3. Product benchmarking

9.3.15.4. Strategic initiatives

9.3.16. Orange

9.3.16.1. Company overview

9.3.16.2. Financial performance

9.3.16.3. Product benchmarking

9.3.16.4. Strategic initiatives

9.3.17. Qualcomm Technologies, Inc.

9.3.17.1. Company overview

9.3.17.2. Financial performance

9.3.17.3. Product benchmarking

9.3.17.4. Strategic initiatives

9.3.18. Softserve

9.3.18.1. Company overview

9.3.18.2. Financial performance

9.3.18.3. Product benchmarking

9.3.18.4. Strategic initiatives

9.3.19. Computer Programs and Systems, Inc.

9.3.19.1. Company overview

9.3.19.2. Financial performance

9.3.19.3. Product benchmarking

9.3.19.4. Strategic initiatives

9.3.20. Vocera Communications

9.3.20.1. Company overview

9.3.20.2. Financial performance

9.3.20.3. Product benchmarking

9.3.20.4. Strategic initiatives

9.3.21. IBM Corporation

9.3.21.1. Company overview

9.3.21.2. Financial performance

9.3.21.3. Product benchmarking

9.3.21.4. Strategic initiatives

9.3.22. CISCO Systems, Inc.

9.3.22.1. Company overview

9.3.22.2. Financial performance

9.3.22.3. Product benchmarking

9.3.22.4. Strategic initiatives